{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:44:29Z","timestamp":1788374669151,"version":"build-2803163510"},"reference-count":178,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ando.2023.01.005","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T10:56:23Z","timestamp":1675248983000},"page":"272-284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-0072","authenticated-orcid":false,"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider","family":"Pascual-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2023.01.005_bib0895","doi-asserted-by":"crossref","first-page":"M133","DOI":"10.1530\/EJE-15-0354","article-title":"Metabolic comorbidities in Cushing's syndrome","volume":"173","author":"Ferra\u00f9","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib0900","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib0905","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib0910","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2023.01.005_bib0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314297","article-title":"Epidemiology of Cushing's syndrome","volume":"92","author":"Steffensen","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2023.01.005_bib0920","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib0925","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: A 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib0930","first-page":"520","article-title":"Risk factors and long-term follow-up of adrenal incidentalomas","volume":"84","author":"Barzon","year":"1999","journal-title":"JClinEndocrinolMetab"},{"key":"10.1016\/j.ando.2023.01.005_bib0935","first-page":"10","article-title":"Predictors of tumour growth and autonomous cortisol secretion development during follow-up in non-functioning adrenal incidentalomas","author":"Araujo-Castro","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.ando.2023.01.005_bib0940","first-page":"64","article-title":"Autonomous cortisol secretion in adrenal incidentalomas","author":"Araujo-Castro","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib0945","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.metabol.2010.01.007","article-title":"Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: A cause-effect relationship?","volume":"59","author":"Peppa","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2023.01.005_bib0950","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4158\/EP-2020-0182","article-title":"Nonfunctioning adrenal incidentalomas are not clinically silent: A longitudinal cohort study","volume":"26","author":"Kim","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.01.005_bib0955","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12020-021-02741-x","article-title":"Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis","volume":"74","author":"Athanasouli","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib0960","first-page":"1","article-title":"Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas","volume":"20","author":"Araujo-Castro","year":"2021","journal-title":"Horm"},{"key":"10.1016\/j.ando.2023.01.005_bib0965","article-title":"Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study","author":"Araujo-Castro","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib0970","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.eprac.2022.06.007","article-title":"A Proposal for Nomenclature Revision of Non-functioning Adrenal Incidentalomas as Adrenal Lesions of Undetermined Secretion of Adrenal Steroids (ALUSAS)","volume":"28","author":"Araujo-Castro","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.01.005_bib0975","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.endinu.2019.01.004","article-title":"SEEN guidelines for the management and prevention of acute adrenal insufficiency","volume":"67","author":"Araujo Castro","year":"2019","journal-title":"Endocrinol Diabetes y Nutr"},{"key":"10.1016\/j.ando.2023.01.005_bib0980","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib0985","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"The Incidentally Discovered Adrenal Mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2023.01.005_bib0990","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib0995","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.01.005_bib1000","unstructured":"Incidentally discovered adrenal tumors: an institutional perspective - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/1745970\/(accessed September 30, 2022)."},{"key":"10.1016\/j.ando.2023.01.005_bib1005","doi-asserted-by":"crossref","DOI":"10.7326\/M22-1619","article-title":"Prevalence and Characteristics of Adrenal Tumors in an Unselected Screening Population: A Cross-Sectional Study","author":"Jing","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4615-6355-6_13","article-title":"Incidentally discovered adrenal masses","volume":"89","author":"Kloos","year":"1997","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1015","first-page":"23","article-title":"Pathophysiological Link between Insulin Resistance and Adrenal Incidentalomas","author":"Higgs","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ando.2023.01.005_bib1020","doi-asserted-by":"crossref","DOI":"10.7326\/M22-2600","article-title":"Adrenal Incidentalomas: Insights Into Prevalence","author":"Bancos","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1025","first-page":"117","article-title":"Incidence and late prognosis of cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1030","doi-asserted-by":"crossref","DOI":"10.1007\/s11102-018-0894-2","article-title":"Two types of ectopic Cushing syndrome or a continuum?","author":"Araujo Castro","year":"2018","journal-title":"Review. Pituitary"},{"key":"10.1016\/j.ando.2023.01.005_bib1035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1530\/EJE-11-1039","article-title":"Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: A large cross-sectional study","volume":"166","author":"Di Dalmazi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1040","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/BF03345772","article-title":"Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas","volume":"32","author":"Yilmaz","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.01.005_bib1045","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.endinu.2019.01.007","article-title":"Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome","volume":"66","author":"Emral","year":"2019","journal-title":"Endocrinol Diabetes y Nutr"},{"key":"10.1016\/j.ando.2023.01.005_bib1050","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: A systematic review and meta-Analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.4103\/ijem.IJEM_52_19","article-title":"Nonfunctioning and subclinical cortisol secreting adrenal incidentalomas and their association with metabolic syndrome: A systematic review","volume":"23","author":"Khan","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1060","first-page":"57","article-title":"Markers of subclinical cardiovascular disease in nonfunctional adrenal incidentaloma patients without traditional cardiovascular risk factors","volume":"125","author":"Cansu","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2023.01.005_bib1065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41371-017-0011-4","article-title":"The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test","volume":"32","author":"Arruda","year":"2017","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.ando.2023.01.005_bib1070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/eje.0.1480213","article-title":"Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery","volume":"148","author":"Bernini","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1075","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1365-2265.2001.01274.x","article-title":"The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection","volume":"54","author":"Midorikawa","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1080","first-page":"78","article-title":"Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion","author":"Araujo-Castro","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1085","first-page":"1440","article-title":"Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical features","volume":"85","author":"Rossi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1090","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1210\/jc.2009-2387","article-title":"Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism","volume":"95","author":"Chiodini","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1095","article-title":"Hypertension Resolution after Laparoscopic Adrenal Tumor Resection in Patients of Adrenal Incidentaloma with Normal Hormone Levels","author":"Wang","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.ando.2023.01.005_bib1100","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4158\/EP-2020-0182","article-title":"Nonfunctioning Adrenal Incidentalomas are not Clinically Silent: A Longitudinal Cohort Study","volume":"26","author":"Kim","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.01.005_bib1105","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","article-title":"Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis","volume":"37","author":"Tuna","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.01.005_bib1110","article-title":"Frequency of masked hypertension in patients with nonfunctioning adrenal incidentalomas with normal and high normal blood pressure","author":"Y\u0131lmaz","year":"2021","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.ando.2023.01.005_bib1115","first-page":"20","article-title":"The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients\u2019 stratification by body mass index and age","author":"Podbregar","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.ando.2023.01.005_bib1120","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2174\/1871530320666200910110337","article-title":"Increased Rates of Coronary Artery Calcium Score in Patients with Non - Functioning Adrenal Incidentaloma. Endocrine","volume":"21","author":"Akkus","year":"2020","journal-title":"Metab Immune Disord - Drug Targets"},{"key":"10.1016\/j.ando.2023.01.005_bib1125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40618-020-01360-z","article-title":"Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed","volume":"44","author":"de Paula","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.01.005_bib1130","first-page":"14","article-title":"The Relationship Between Increased Epicardial Fat Thickness and Left Ventricular Hypertrophy and Carotid Intima-Media Thickness in Patients With Nonfunctional Adrenal Incidentaloma","author":"Imga","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.kjms.2017.04.002","article-title":"Comparison of echocardiographic findings in patients with nonfunctioning adrenal incidentalomas","volume":"33","author":"Imga","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.ando.2023.01.005_bib1140","first-page":"656","article-title":"Assessment of subclinical cardiac alterations and atrial electromechanical delay by tissue doppler echocardiography in patients with nonfunctioning adrenal incidentaloma","volume":"111","author":"Sokmen","year":"2018","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ando.2023.01.005_bib1145","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12020-009-9160-8","article-title":"Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma","volume":"35","author":"Yener","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1150","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s12020-017-1439-6","article-title":"Nonfunctioning adrenal incidentaloma affecting central blood pressure and arterial stiffness parameters","volume":"58","author":"Akkan","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejim.2011.08.009","article-title":"Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas","volume":"23","author":"Yener","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1160","unstructured":"Gimeno PG, Fern\u00e1ndez-ladreda MT. Endocrine Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test>0. 9\u03bcg\/dL have a higher prevalence of cardiovascular disease than those with 2019."},{"key":"10.1016\/j.ando.2023.01.005_bib1165","first-page":"105","article-title":"Bone Evaluation by High-Resolution Peripheral Quantitative Computed Tomography in Patients With Adrenal Incidentaloma","author":"Moraes","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1170","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cen.13743","article-title":"Assessment of vertebral microarchitecture in overt and mild Cushing's syndrome using trabecular bone score","volume":"89","author":"Vinolas","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1175","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/jbmr.1648","article-title":"Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism","volume":"27","author":"Eller-Vainicher","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1180","unstructured":"Adrenal incidentaloma: effects on bone metabolism - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/18791352\/(accessed October 12, 2022)."},{"key":"10.1016\/j.ando.2023.01.005_bib1185","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1210\/jc.2013-4064","article-title":"Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion","volume":"99","author":"Androulakis","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1190","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/M16-0547","article-title":"\u201cNonfunctional\u201d adrenal Tumors and the risk for incident diabetes and cardiovascular outcomes: A cohort study","volume":"165","author":"Lopez","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrendo.2016.139","article-title":"Adrenal gland: \u201cNonfunctional\u201d adrenal tumours increase diabetes risk","volume":"12","author":"Geach","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1200","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.4158\/EP-2020-0182","article-title":"Nonfunctioning adrenal incidentalomas are not clinically silent: A longitudinal cohort study","volume":"26","author":"Kim","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.01.005_bib1205","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2796.2010.02291.x","article-title":"Adrenal incidentalomas and cardiometabolic morbidity: An emerging association with serious clinical implications","volume":"268","author":"Peppa","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1210","doi-asserted-by":"crossref","unstructured":"Moraes AB, Cavalari EMR, de Paula MP, Arruda M, Curi DSC, Leit\u00e3o RA, et al. Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome? 2019;42:797-807","DOI":"10.1007\/s40618-018-0985-y"},{"key":"10.1016\/j.ando.2023.01.005_bib1215","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/cen.13822","article-title":"Nonfunctioning adrenal incidentaloma: A novel predictive factor for metabolic syndrome","volume":"89","author":"Ribeiro Cavalari","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1220","article-title":"Evaluation of body composition in patients with and without adrenal tumors and without overt hypersecretory syndromes","author":"Araujo-Castro","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.01.005_bib1225","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1230","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus","volume":"69","author":"Tabarin","year":"2008","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.ando.2023.01.005_bib1235","doi-asserted-by":"crossref","DOI":"10.4158\/EP161682.CS","article-title":"Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2017 executive summary","author":"Garber","year":"2017","journal-title":"Endocr Pr"},{"key":"10.1016\/j.ando.2023.01.005_bib1240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.7326\/0003-4819-138-5-200303040-00013","article-title":"Management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d)","volume":"138","author":"Grumbach","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2265.1982.tb00733.x","article-title":"Dexamethasone Suppression Tests: Usefulness of Simultaneous Measurement of Plasma Cortisol and Dexamethasone","volume":"16","author":"Meikle","year":"1982","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1250","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s40618-020-01197-6","article-title":"Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation","volume":"43","author":"Ceccato","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.01.005_bib1255","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/EJE-17-0078","article-title":"Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test","volume":"176","author":"Ueland","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1260","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/clinchem\/hvab056","article-title":"Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome","volume":"67","author":"Vogg","year":"2021","journal-title":"Clin Chem"},{"key":"10.1016\/j.ando.2023.01.005_bib1265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-0029-1210910","article-title":"The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test","volume":"94","author":"Nickelsen","year":"1989","journal-title":"Exp Clin Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1270","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1275","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.endinu.2020.03.002","article-title":"Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition","volume":"67","author":"Araujo-Castro","year":"2020","journal-title":"Endocrinol Diabetes y Nutr"},{"key":"10.1016\/j.ando.2023.01.005_bib1280","article-title":"Low DHEAS: A sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas","author":"Dennedy","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1285","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s12020-014-0387-7","article-title":"DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?","volume":"48","author":"Yener","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1290","first-page":"9","article-title":"Diagnostic Accuracy of Dehydroepiandrosterone Sulfate and Corticotropin in Autonomous Cortisol Secretion","author":"Carafone","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ando.2023.01.005_bib1295","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the Patient With Adrenal Incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1300","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/EJE-09-0957","article-title":"Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas","volume":"162","author":"Giordano","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1305","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12020-016-1007-5","article-title":"Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome","volume":"55","author":"Prete","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1310","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1210\/jc.2014-3766","article-title":"Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how?","volume":"100","author":"Raff","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1315","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.steroids.2010.08.007","article-title":"Diagnostic performance of salivary cortisol and serum osteocalcin measurements in patients with overt and subclinical Cushing's syndrome","volume":"76","author":"Sereg","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.ando.2023.01.005_bib1320","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1530\/EC-20-0419","article-title":"Diagnostic testing of autonomous cortisol secretion in adrenal incidentalomas","volume":"9","author":"Ueland","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2023.01.005_bib1325","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12020-017-1421-3","article-title":"Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma","volume":"59","author":"Ceccato","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1330","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cen.13803","article-title":"Extensive clinical experience: Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess","volume":"89","author":"Hurtado","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1335","doi-asserted-by":"crossref","unstructured":"Delivanis DA, I\u00f1iguez-Ariza NM, Zeb MH, Moynagh MR, Takahashi N, McKenzie TJ, et al. Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas 2018;88:209-16. https:\/\/doi.org\/10.1111\/CEN.13512","DOI":"10.1111\/cen.13512"},{"key":"10.1016\/j.ando.2023.01.005_bib1340","doi-asserted-by":"crossref","first-page":"E973","DOI":"10.1210\/clinem\/dgz284","article-title":"Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study","volume":"105","author":"Reimondo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1345","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2014-1401","article-title":"Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: A systematic review of the literature","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.15.S1.1","article-title":"The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas","volume":"15","author":"Zeiger","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/j.ando.2023.01.005_bib1355","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1360","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1365","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/MED.0000000000000153","article-title":"Adrenal adenomas, subclinical hypercortisolism, and cardiovascular outcomes","volume":"22","author":"Di Dalmazi","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ando.2023.01.005_bib1370","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: An Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1375","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2265.2008.03492.x","article-title":"Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study","volume":"70","author":"Vassilatou","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1380","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-08-0707","article-title":"Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: A long-term follow-up study","author":"Sereg","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1385","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12020-020-02297-2","article-title":"Cardiovascular and metabolic risk factors in patients with subclinical Cushing","volume":"70","author":"Petramala","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1390","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/EJE-17-0047","article-title":"Cardiovascular events in patients with mild autonomous cortisol secretion: Analysis with artificial neural networks","volume":"177","author":"Morelli","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1395","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1400","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1210\/clinem\/dgab468","article-title":"Cardiometabolic Outcomes and Mortality in Patients with Adrenal Adenomas in a Population-based Setting","volume":"106","author":"Zhang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1405","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00268-009-0178-0","article-title":"Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality?","volume":"33","author":"Erbil","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2023.01.005_bib1410","first-page":"56","article-title":"Markers of subclinical cardiovascular disease in patients with adrenal incidentaloma","author":"Szychli\u0144ska","year":"2020","journal-title":"Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1415","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12020-013-9902-5","article-title":"Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma","volume":"44","author":"Iacobellis","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1420","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1530\/EJE-17-0986","article-title":"Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas","volume":"178","author":"Sbardella","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1425","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/jc.2009-0468","article-title":"Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: An Italian multicenter study","volume":"94","author":"Chiodini","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1430","doi-asserted-by":"crossref","DOI":"10.1210\/jcem.86.11.8022","article-title":"Bone loss rate in adrenal incidentalomas: A longitudinal study","author":"Chiodini","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1435","doi-asserted-by":"crossref","unstructured":"Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, et al. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures 2009;70:208-13.","DOI":"10.1111\/j.1365-2265.2008.03310.x"},{"key":"10.1016\/j.ando.2023.01.005_bib1440","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/jbmr.398","article-title":"Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study","volume":"26","author":"Morelli","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1445","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-147-8-200710160-00006","article-title":"Subclinical hypercortisolism among outpatients referred for osteoporosis","volume":"147","author":"Chiodini","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1450","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1210\/jcem.86.11.8022","article-title":"Bone loss rate in adrenal incidentalomas: A longitudinal study","volume":"86","author":"Chiodini","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1455","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1210\/jc.2003-031413","article-title":"Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status","volume":"89","author":"Chiodini","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1460","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/jcem.84.7.5856","article-title":"Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism","volume":"84","author":"Torlontano","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1465","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/eje.0.1450241","article-title":"Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass","volume":"145","author":"Tauchmanov\u00e0","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1470","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1210\/jc.2002-020399","article-title":"Bone involvement in eugonadal male patients with adrenal incidentaloma and subclinical hypercortisolism","volume":"87","author":"Chiodini","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1475","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1210\/jc.2016-1423","article-title":"Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas","volume":"101","author":"Morelli","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1480","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bone.2015.05.016","article-title":"Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice","volume":"78","author":"Harvey","year":"2015","journal-title":"Bone"},{"key":"10.1016\/j.ando.2023.01.005_bib1485","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1490","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bone.2005.04.003","article-title":"Prognostic utility of a semiquantitative spinal deformity index","volume":"37","author":"Crans","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.ando.2023.01.005_bib1495","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00198-006-0199-6","article-title":"Severity of vertebral fracture reflects deterioration of bone microarchitecture","volume":"18","author":"Genant","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2023.01.005_bib1500","doi-asserted-by":"crossref","DOI":"10.1210\/er.2018-00097","article-title":"Glucocorticoids and bone: Consequences of endogenous and exogenous excess and replacement therapy","volume":"39","author":"Hardy","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.01.005_bib1505","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jdiacomp.2016.05.006","article-title":"Prevalence of subclinical hypercortisolism in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study","volume":"30","author":"Costa","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ando.2023.01.005_bib1510","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1530\/eje.1.02045","article-title":"Association of subclinical hypercortisolism with type 2 diabetes mellitus: A case-control study in hospitalized patients","volume":"153","author":"Chiodini","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1515","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/jc.2009-2453","article-title":"Is there value in routine screening for Cushing's syndrome in patients with diabetes?","volume":"95","author":"Mullan","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1520","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2265.1996.737558.x","article-title":"Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients","volume":"44","author":"Leibowitz","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1525","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.2007.02865.x","article-title":"Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus","volume":"67","author":"Reimondo","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1530","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2012-1323","article-title":"Screening of Cushing's syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy","volume":"97","author":"Terzolo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1535","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1507\/endocrj.K07E-045","article-title":"Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus","volume":"55","author":"Taniguchi","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.01.005_bib1540","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1507\/endocrj.K09E-352","article-title":"The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing's disease","volume":"57","author":"Murakami","year":"2010","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.01.005_bib1545","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/jc.2001-011766","article-title":"Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk","volume":"87","author":"Tauchmanov\u00e0","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1550","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2265.2010.03794.x","article-title":"Subclinical hypercortisolism: Correlation between biochemical diagnostic criteria and clinical aspects","volume":"73","author":"Morelli","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1555","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.suc.2004.01.001","article-title":"Subclinical Cushing's syndrome in adrenal incidentalomas","volume":"84","author":"Sippel","year":"2004","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.ando.2023.01.005_bib1560","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","article-title":"Adrenal incidentaloma: A new cause of the metabolic syndrome?","volume":"87","author":"Terzolo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1565","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1210\/er.2016-1105","article-title":"Glucose metabolism abnormalities in cushing syndrome: From molecular basis to clinical management","volume":"38","author":"Scaroni","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2023.01.005_bib1570","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/eje.1.01959","article-title":"Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma","volume":"153","author":"Terzolo","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1575","doi-asserted-by":"crossref","first-page":"22","DOI":"10.14310\/horm.2002.1716","article-title":"Which type 2 diabetes mellitus patients should be screened for subclinical Cushing's syndrome?","volume":"16","author":"Cansu","year":"2017","journal-title":"Hormones"},{"key":"10.1016\/j.ando.2023.01.005_bib1580","unstructured":"Glucose and lipid abnormalities in patients with adrenal incidentalomas - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/31802038\/(accessed December 29, 2022)."},{"key":"10.1016\/j.ando.2023.01.005_bib1585","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07435809609043773","article-title":"Adrenal incidentalomas: A manifestation of the metabolic syndrome?","volume":"22","author":"Reincke","year":"1996","journal-title":"Endocr Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1590","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.metabol.2012.12.006","article-title":"Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications","volume":"62","author":"Ivovi\u0107","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2023.01.005_bib1595","doi-asserted-by":"crossref","first-page":"991","DOI":"10.12659\/MSM.897714","article-title":"Carotid Intima-Media Thickness as the Cardiometabolic Risk Indicator in Patients with Nonfunctional Adrenal Mass and Metabolic Syndrome Screening","volume":"22","author":"Evran","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ando.2023.01.005_bib1600","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s40618-014-0232-0","article-title":"Lipid abnormalities in patients with adrenal incidentalomas: Role of subclinical hypercortisolism and impaired glucose metabolism","volume":"38","author":"Masserini","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2023.01.005_bib1605","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2265.2004.02154.x","article-title":"Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals","volume":"61","author":"Zoppini","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1610","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ando.2023.01.005_bib1615","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1464-5491.2005.01583.x","article-title":"Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients","volume":"22","author":"Targher","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.ando.2023.01.005_bib1620","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1210\/jc.2003-030596","article-title":"Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver","volume":"88","author":"Westerbacka","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1625","first-page":"479","article-title":"Influence of plasma cortisol and other laboratory parameters on nonalcoholic Fatty liver disease","volume":"47","author":"Hubel","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1630","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2362.2012.02707.x","article-title":"Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma","volume":"42","author":"Papanastasiou","year":"2012","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ando.2023.01.005_bib1635","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1507\/endocrj.EJ14-0539","article-title":"Activity of selected coagulation factors in overt and subclinical hypercortisolism","volume":"62","author":"\u015awiatkowska-Stodulska","year":"2015","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.01.005_bib1640","doi-asserted-by":"crossref","first-page":"E130","DOI":"10.1210\/clinem\/dgaa695","article-title":"Mental Health in Patients With Adrenal Incidentalomas: Is There a Relation With Different Degrees of Cortisol Secretion?","volume":"106","author":"Morelli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1645","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.surg.2016.07.042","article-title":"Outcome of adrenalectomy for subclinical hypercortisolism and Cushing syndrome","volume":"161","author":"Raffaelli","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.01.005_bib1650","first-page":"991","article-title":"Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome","volume":"152","author":"Iacobone","year":"2012","journal-title":"Surg (United States)"},{"key":"10.1016\/j.ando.2023.01.005_bib1655","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical cushing syndrome in adrenal incidentalomas: A prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2023.01.005_bib1660","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1507\/endocrj.K07E-177","article-title":"Cardiovascular risks and their long-term clinical outcome in patients with subclinical Cushing's syndrome","volume":"55","author":"Tsuiki","year":"2008","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.01.005_bib1665","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.surg.2007.10.001","article-title":"Subclinical Cushing's syndrome\u201d is not subclinical: improvement after adrenalectomy in 9 patients","volume":"142","author":"Mitchell","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2023.01.005_bib1670","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.50.399","article-title":"Prevalence of subclinical Cushing's syndrome in 70 patients with adrenal incidentaloma: Clinical, biochemical and surgical outcomes","volume":"50","author":"Emral","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2023.01.005_bib1675","doi-asserted-by":"crossref","first-page":"E103","DOI":"10.1210\/clinem\/dgaa774","article-title":"Diabetes, Active Disease, and Afternoon Serum Cortisol Levels Predict Cushing's Disease Mortality: A Cohort Study","volume":"106","author":"Rold\u00e1n-Sarmiento","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1680","article-title":"Hypercoagulability in Cushing Syndrome, Prevalence of Thrombotic Events: A Large, Single-Center, Retrospective Study","volume":"4","author":"Suarez","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2023.01.005_bib1685","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12020-018-1819-6","article-title":"Factors predicting long-term comorbidities in patients with Cushing's syndrome in remission","volume":"64","author":"Schernthaner-Reiter","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2023.01.005_bib1690","first-page":"34","article-title":"Clinical presentation and etiology of Cushing's syndrome: Data from ERCUSYN","author":"Valassi","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1695","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2265.2011.04055.x","article-title":"Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission","volume":"75","author":"Giordano","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1700","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2012-3547","article-title":"Coronary artery disease detected by multislice computed tomography in patients after long-term cure of Cushing's syndrome","volume":"98","author":"Barahona","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1705","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1530\/EJE-20-1309","article-title":"Management of endocrine disease: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach","volume":"184","author":"Varlamov","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1710","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1715","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1210\/clinem\/dgaa291","article-title":"Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission: A Swedish Nationwide Study","volume":"105","author":"Papakokkinou","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1720","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1725","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fendo.2018.00805","article-title":"Hypercoagulability and Risk of Venous Thromboembolic Events in Endogenous Cushing's Syndrome: A Systematic Meta-Analysis","volume":"9","author":"Wagner","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2023.01.005_bib1730","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.12094","article-title":"Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatment","volume":"78","author":"Van Der Pas","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2023.01.005_bib1735","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery","volume":"163","author":"Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1740","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1210\/jc.2011-1661","article-title":"Incidence of venous thromboembolism in patients with Cushing's syndrome: a multicenter cohort study","volume":"96","author":"Stuijver","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1745","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11102-011-0306-3","article-title":"Spontaneous recovery of bone mass after cure of endogenous hypercortisolism","volume":"15","author":"Randazzo","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2023.01.005_bib1750","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/jbmr.4309","article-title":"The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up Study","volume":"36","author":"Braun","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2023.01.005_bib1755","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1210\/jc.2002-021558","article-title":"Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission","volume":"88","author":"Faggiano","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1760","first-page":"34","article-title":"Glucose and lipid metabolism abnormalities in Cushing's syndrome","author":"Salehidoost","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1765","first-page":"6","article-title":"Increased Mortality Persists after Treatment of Cushing's Disease: A Matched Nationwide Cohort Study","author":"Bengtsson","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.ando.2023.01.005_bib1770","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2023.01.005_bib1775","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-14-0556","article-title":"Management of endocrine disease: Mortality remains increased in Cushing's disease despite biochemical remission: A systematic review and meta-analysis","author":"Van Haalen","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2023.01.005_bib1780","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426623000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:54:55Z","timestamp":1757717695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426623000288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":178,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0003426623000288"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2023.01.005","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2023.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}